| |
|
 |
Lajos Balogh PhD
Editor-in-Chief
NanoMedicine: Nanotechnolgy, Biology & Medicine |
| Lajos (Lou) Balogh is the Editor-in-Chief of the journal Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier). He is presently the CEO of AA NANOMED Consulting and a former Professor of the Roswell Park Cancer Institute, of the University at Buffalo, SUNY, and of the University of Michigan, Ann Arbor, MI.
Dr. Balogh received his Ph.D. from the Kossuth L. University (KLTE) in Hungary in Chemical Technology. After being on the faculty of KLTE for 15 years teaching Chemical Engineering and researching pharmaceutics and polymers, he was invited to work at the University of Massachusetts, Lowell, MA, and moved to the USA. In 1996 he joined the ARL=MMI Dendrimer Center of Excellence in Midland, MI, as a senior associate scientist before moving to Ann Arbor.
Lou has authored/coauthored over 150 scientific publications and has been awarded 12 patents in various disciplines. He is a world-recognized scientist in the field of nanomedicine, composite nanoparticles and dendrimers. His present research interests involve the design, synthesis, and characterization of multifunctional hybrid nanodevices for targeted delivery of smart contrast agents and anticancer drugs as well as the interactions of these nanodevices with cells and tissues, especially as it applies to cancer.
Dr. Balogh is a member of numerous expert committees, including the NIH NANO and the EPA Nanotechnology study sections. Lou is one of the five Founders of the American Society for Nanomedicine (ASNM), He is also a member of the Steering Committee of the American National Standard Institute Nanotechnology Panel and serves on the TC-229 Technical Advisory Committee to the International Standard Organization on Nanotechnology.
|
 |
 |
|
|
|
|
|
